Bo Feng

Bo Feng


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in Systems
Verified
Journal Article
Open access
PDF file
AGAmirkeyvan Ghazvinian
Amirkeyvan Ghazvinian
BFBo Feng
Bo Feng
JFJunwen Feng
Junwen Feng
The purpose of this paper is to examine the optimization of the HIV drug supply chain, with a dual focus on minimizing freight costs and delivery times. With the help of a dataset containing 10,325 instances of supply chain transactions, key variables, including “Country”, “Vendor INCO Term”, and “Shipment Mode”, were examined in order to develop a predictive model using Artificial Neural Networks (ANN) employing a Multi-Layer Perceptron (MLP) architecture. A set of ANN models were trained to forecast “freight cost” and “delivery time” based on four principal design variables: “Line Item Quantity”, “Pack Price”, “Unit of Measure (Per Pack)”, and “Weight (Kilograms)”. According to performance metrics analysis, these models demonstrated predictive accuracy following training. An optimization algorithm, configured with an “active-set” algorithm, was then used to minimize the combined objective function of freight cost and delivery time. Both freight costs and delivery times were significantly reduced as a result of the optimization. This study illustrates the potent application of machine learning and optimization algorithms to the enhancement of supply chain efficiency. This study provides a blueprint for cost reduction and improved service delivery in critical medication supply chains based on the methodology and outcomes.

6 November 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
AGAmirkeyvan Ghazvinian
Amirkeyvan Ghazvinian
BFBo Feng
Bo Feng
JFJunwen Feng
Junwen Feng
Introduction: Millions of people living with HIV around the world depend on having access to antiretroviral (ARV) drugs, yet the supply chain continues to confront obstacles like rising freight costs and delivery delays. These inefficiencies put timely access to life-saving medications at risk, especially in resource-limited settings. To find ways to improve the HIV drug supply chain, this study looks into the underlying causes of these disruptions. Objectives: This study aims to: (1) assess and prioritize risks in the HIV drug supply chain, focusing on failure modes impacting delivery timelines and freight costs; and (2) enhance supply chain substantivity (fulfillment capacity) and resilience (disruption adaptability) through evidence-based strategies. Methods: Using Z-numbers to handle uncertainty, we developed a hybrid multi-criteria decision-making framework that integrates Z-SWARA, Z-WASPAS, and Z-DEA-FMEA. Along with using FMEA to assess risks and identify failure modes, the method ranks them based on freight costs and delivery timeliness, using hybrid rankings, RPN, Z-SWARA/Z-WASPAS, and Z-DEA-FMEA efficiencies. Results: Hybrid rankings indicate that the primary contributors to supply chain inefficiencies are Quantity Errors (F14, ranked 1st, 𝑄𝑡𝑜𝑡𝑎𝑙=0.9374), Pack Price Discrepancies (F16, ranked 2nd, 0.8430), and Unit Miscalculation (F13, ranked 3rd, 0.7261). The Z-WASPAS analysis emphasizes the financial implications of F16, placing it at the top for Freight Costs ( K = 0.178). Additionally, Z-DEA-FMEA notes efficiency shifts including Delivery Confirmation (F06, 𝜃=0.7303, Delivery). In the case of Weight Failures (F20), the Freight score (𝑄𝑖=0.6991, ranked 3rd) surpasses that of Delivery (0.6753, ranked 4th), while Shipment Mode Selection (F04) holds the 5th position overall (𝑄𝑡𝑜𝑡𝑎𝑙=0.6741). Discussion: Aiming to improve the availability of antiretroviral (ARV) medications, our approach integrates risk, uncertainty, and efficiency analysis to formulate evidence-based strategies by utilizing Z-numbers. It redefines concepts of resilience and substantivity, providing decision-makers with a framework to enhance delivery speed and minimize costs. These improvements strengthen global health logistics.